Add to ORKGThis article was published in the Spring 2012 issue of the Journal of Undergraduate Researc
During the 2008 heparin crisis, a tainted blood-thinning drug imported from China caused the deaths ...
The complex ways in which technical challenges of trial design provoke, and are provoked by, ethical...
For well over a decade the U.S. Food and Drug Administration (FDA) has been told that its framework ...
This article was published in the Spring 2012 issue of the Journal of Undergraduate Researc
Currently, pharmaceutical companies\u27 utilization of foreign clinical trial data is a ubiquitous a...
In recent years, U.S. pharmaceutical companies have expanded their new drug trials beyond the border...
Research and development of pharmaceuticals are now complex global endeavors, with drug companies op...
Given the tremendous financial reward that a blockbuster therapy might generate, there are strong in...
With the increasing accessibility of cheap internet communication, human research subjects and conce...
Developing countries are a fertile testing ground for the research and development of new drug produ...
The Office of Inspector General, US Department of Health and Human Services, released a report in Ju...
The Food and Drug Administration (FDA) is responsible for approving and regulating all drugs in the ...
Regulators must often make difficult decisions based on uncertain or limited information. When it co...
Four years ago, the US Food and Drug Administration (FDA) ceased compliance with the Declaration of ...
This Article reexamines the role of FDA regulation in motivating investment in biopharmaceutical inn...
During the 2008 heparin crisis, a tainted blood-thinning drug imported from China caused the deaths ...
The complex ways in which technical challenges of trial design provoke, and are provoked by, ethical...
For well over a decade the U.S. Food and Drug Administration (FDA) has been told that its framework ...
This article was published in the Spring 2012 issue of the Journal of Undergraduate Researc
Currently, pharmaceutical companies\u27 utilization of foreign clinical trial data is a ubiquitous a...
In recent years, U.S. pharmaceutical companies have expanded their new drug trials beyond the border...
Research and development of pharmaceuticals are now complex global endeavors, with drug companies op...
Given the tremendous financial reward that a blockbuster therapy might generate, there are strong in...
With the increasing accessibility of cheap internet communication, human research subjects and conce...
Developing countries are a fertile testing ground for the research and development of new drug produ...
The Office of Inspector General, US Department of Health and Human Services, released a report in Ju...
The Food and Drug Administration (FDA) is responsible for approving and regulating all drugs in the ...
Regulators must often make difficult decisions based on uncertain or limited information. When it co...
Four years ago, the US Food and Drug Administration (FDA) ceased compliance with the Declaration of ...
This Article reexamines the role of FDA regulation in motivating investment in biopharmaceutical inn...
During the 2008 heparin crisis, a tainted blood-thinning drug imported from China caused the deaths ...
The complex ways in which technical challenges of trial design provoke, and are provoked by, ethical...
For well over a decade the U.S. Food and Drug Administration (FDA) has been told that its framework ...